A new prebiotic from germinated barley for nutraceutical treatment of ulcerative colitis

被引:76
作者
Bamba, T
Kanauchi, O
Andoh, A
Fujiyama, Y
机构
[1] Kirin Brewery Co Ltd, Nutrient Food & Feed Div, Chuo Ku, Tokyo 1048288, Japan
[2] Shiga Univ Med Sci, Dept Internal Med, Shiga, Japan
关键词
Bifidobacterium; butyrate; dietary fiber; Eubacterium limosum; inflammation; microflora; prebiotics; ulcerative colitis;
D O I
10.1046/j.1440-1746.2002.02709.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A germinated barley foodstuff (GBF) containing glutamine-rich protein and hemicellulose-rich fiber was made from brewer's spent grain, by physical isolation. Our previous studies demonstrated that GBF supported maintenance of epithelial cell populations, facilitated epithelial repair, and suppressed epithelial nuclear factor kappaB-DNA-binding activity through generating increased short-chain fatty acid (especially butyrate) production by luminal microflora, which includes Bifidobacterium and Eubacterium, thereby preventing experimental colonic injury. The fiber fraction also modulates stool water content because of its high water-holding capacity. The patients with mild to moderate active ulcerative colitis who had been unresponsive to or intolerant of standard treatment received 20-30 g GBF, feeding daily in a non-randomized, open-label fashion. At 4 weeks, this treatment resulted in a significant clinical and endoscopic improvement. The improvement was associated with an increase in stool butyrate concentrations. These results indicate that GBF feeding is a potentially new, attractive prebiotic treatment in patients with ulcerative colitis. The potency of GBF on modulating microflora, as well as the high water-holding capacity, may play an important role in treatment and prolongation of remission in ulcerative colitis.
引用
收藏
页码:818 / 824
页数:7
相关论文
共 44 条
  • [21] Germinated barley foodstuffs attenuate colonic mucosal damage and mucosal nuclear factor kappa B activity in a spontaneous colitis model
    Kanauchi, O
    Andoh, A
    Iwanaga, T
    Fujiyama, Y
    Mitsuyama, K
    Toyonaga, A
    Bamba, T
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 14 (12) : 1173 - 1179
  • [22] Kanauchi O, 1999, INT J MOL MED, V3, P175
  • [23] Kanauchi O, 1998, INT J MOL MED, V1, P961
  • [24] KANAUCHI O, 2001, J JPN SOC CLIN NU S1, V23, P21
  • [25] KANAUCHI O, 2001, JPEN, V23, P543
  • [26] L-glutamine enemas attenuate mucosal injury in experimental colitis
    Kaya, E
    Gür, ES
    Özgüç, H
    Bayer, A
    Tokyay, R
    [J]. DISEASES OF THE COLON & RECTUM, 1999, 42 (09) : 1209 - 1215
  • [27] CYCLOSPORINE IN SEVERE ULCERATIVE-COLITIS REFRACTORY TO STEROID-THERAPY
    LICHTIGER, S
    PRESENT, DH
    KORNBLUTH, A
    GELERNT, I
    BAUER, J
    GALLER, G
    MICHELASSI, F
    HANAUER, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (26) : 1841 - 1845
  • [28] Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor
    Mashimo, H
    Wu, DC
    Podolsky, DK
    Fishman, MC
    [J]. SCIENCE, 1996, 274 (5285) : 262 - 265
  • [29] Mitsuyama K, 1998, ALIMENT PHARM THERAP, V12, P1225, DOI 10.1046/j.1365-2036.1998.00432.x
  • [30] EFFECT OF DIETARY SUPPLEMENTATION WITH GLUTAMIC-ACID OR GLUTAMINE ON THE SPLANCHNIC AND MUSCLE METABOLISM OF GLUCOGENIC AMINO-ACIDS IN THE RAT
    MOUNDRAS, C
    REMESY, C
    BERCOVICI, D
    DEMIGNE, C
    [J]. JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 1993, 4 (04) : 222 - 228